Key Highlights Charter Communications selects AWS as its GenAI provider, integrating Amazon Q Developer across its engineering ecosystem. GitLab Duo with Amazon Q Developer to streamline software development, boosting speed, automation, and code quality. Companies to co-deploy agentic AI solutions across Charter’s operations, enhancing customer experience and service reliability. Charter Communications has announced a major partnership with Amazon Web Services (AWS) that makes AWS one of Charter’s strategic generative-AI (GenAI) providers. Under this strategic agreement, the partnership is expected to significantly elevate Charter’s software development capabilities, operational efficiency, and customer experience, which are key priorities for the company as it…
Author: Corporate Leaders Magazine
Key Highlights Danone introduces Silk Protein, a high-protein plant-based milk aimed at reviving interest in the declining plant-based dairy category. Silk Protein contains 13 grams of complete plant protein, 50% more protein and half the sugar of traditional dairy milk. Danone targets rising consumer demand for protein-rich, functional beverages as the plant-based milk market faces stagnation. Danone is introducing a new high-protein version of its Silk brand as the company attempts to “reignite interest” in the plant-based dairy sector. With protein now one of the most in-demand functional ingredients in the U.S., Danone sees a major opportunity to bring innovation…
Key Highlights $30 million investment to build a new AI factory (MC-2) in Melbourne, opening January 2026. Cutting-edge infrastructure powered by AMD Instinct MI355 GPUs, EPYC 9575F CPUs and ROCm software to design task-specific AI models. Strategic shift from general-purpose large language models (LLMs) to precision-engineered applied AI built from scratch. In a landmark move for Australia’s artificial intelligence industry, Maincode has announced a $30 million investment to construct what it calls the country’s most advanced AI factory, located in Melbourne. It is scheduled to open in January 2026. Known internally as “MC-2,” the facility will aim to advance Maincode’s…
Key Highlights The U.S. could have saved $1.3 billion-$1.5 billion in the first year post-approval if launch prices for drugs matched value-based benchmarks, says the Institute for Clinical and Economic Review (ICER). Median annual net launch prices for new drugs jumped 51% from 2022 to 2024, while list prices rose 24%, underscoring rapid cost escalation across the healthcare industry. ICER’s analysis shows that Americans continue to pay substantially more for medicines than patients in other high-income nations. A new report from the Institute for Clinical and Economic Review (ICER) estimates that the United States could have saved up to $1.5…